↓ Skip to main content

Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic

Overview of attention for article published in Frontiers in immunology, September 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
14 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
Published in
Frontiers in immunology, September 2022
DOI 10.3389/fimmu.2022.989685
Pubmed ID
Authors

Jonny Jonny, Terawan Agus Putranto, Raoulian Irfon, Enda Cindylosa Sitepu

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 28%
Student > Bachelor 3 12%
Student > Ph. D. Student 2 8%
Student > Master 2 8%
Professor > Associate Professor 1 4%
Other 2 8%
Unknown 8 32%
Readers by discipline Count As %
Medicine and Dentistry 5 20%
Immunology and Microbiology 3 12%
Unspecified 2 8%
Nursing and Health Professions 1 4%
Agricultural and Biological Sciences 1 4%
Other 5 20%
Unknown 8 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2024.
All research outputs
#5,103,062
of 26,498,650 outputs
Outputs from Frontiers in immunology
#5,710
of 33,335 outputs
Outputs of similar age
#99,885
of 439,295 outputs
Outputs of similar age from Frontiers in immunology
#289
of 2,098 outputs
Altmetric has tracked 26,498,650 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,335 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,295 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 2,098 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.